Therapeutic Equivalence of OsvaRen® Tablets and OsvaRen® Granules

NCT02027662 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
61
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Fresenius Medical Care Deutschland GmbH